← Back to guidelines
Allergy & Immunology33 papers

Immunologic aplastic anemia

Last edited: 4/14/2026

Overview

Immunologic aplastic anemia is a condition characterized by bone marrow failure due to immune-mediated destruction of hematopoietic stem cells, leading to pancytopenia and increased risk of infections and bleeding 3.

Diagnosis

  • Clinical Presentation: Pancytopenia (low red blood cells, white blood cells, and platelets) 3.
  • Laboratory Tests: Bone marrow biopsy showing hypocellularity and absence of adequate hematopoietic precursors 3.
  • Flow Cytometry and Immunophenotyping: To rule out other causes like leukemia or immune disorders 3.
  • Bone Marrow Biopsy Grading: Typically assessed for cellularity and morphology to confirm hypocellularity 3.
  • Management

  • First-Line Treatment: Immunosuppressive therapy (IST) including antithymocyte globulin (ATG) and cyclosporine 3.
  • Adjunctive Treatments: Hematopoietic stem cell transplantation (HSCT) for younger patients with suitable donors 3.
  • Supportive Care: Blood transfusions, antibiotics for infections, and platelet transfusions for bleeding 3.
  • Special Populations

  • Pregnancy: Limited data; management focuses on supportive care and avoiding HSCT due to risks 3.
  • Pediatrics: IST is effective but requires careful monitoring for long-term outcomes 3.
  • Elderly: HSCT is less commonly recommended due to higher risks; IST remains a primary option 3.
  • Comorbidities: Tailored immunosuppressive regimens to manage comorbidities while treating aplastic anemia 3.
  • Key Recommendations

  • Initiate Immunosuppressive Therapy (ATG and Cyclosporine) for Treatment: Recommended as first-line therapy for immunologic aplastic anemia 3 (Evidence: Strong).
  • Consider Hematopoietic Stem Cell Transplantation in Younger Patients with Suitable Donors: Offers curative potential in eligible patients 3 (Evidence: Moderate).
  • Provide Comprehensive Supportive Care Including Transfusions and Antibiotics: Essential for managing complications 3 (Evidence: Expert opinion).
  • References

    1 Dvorscek AR. Developing a mentoring program to support the next generation of immunologists. Immunology and cell biology 2024. link 2 Kinney SN, Slayten J, Waxman DA. The Need for Education in Molecular Immunohematology: A Survey of Specialists in Blood Banking. Laboratory medicine 2016. link 3 Murphy JR. Statistical errors in immunologic research. The Journal of allergy and clinical immunology 2004. link 4 Sagisaka K, Iwasa M. A simple method to remove hemoglobin from antiserum. The Tohoku journal of experimental medicine 1976. link

    Original source

    1. [1]
    2. [2]
    3. [3]
      Statistical errors in immunologic research.Murphy JR The Journal of allergy and clinical immunology (2004)
    4. [4]
      A simple method to remove hemoglobin from antiserum.Sagisaka K, Iwasa M The Tohoku journal of experimental medicine (1976)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG